Literature DB >> 23988582

The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways.

Eric L Garland1, Brett Froeliger, Fadel Zeidan, Kaitlyn Partin, Matthew O Howard.   

Abstract

Prescription opioid misuse and addiction among chronic pain patients are emerging public health concerns of considerable significance. Estimates suggest that more than 10% of chronic pain patients misuse opioid analgesics, and the number of fatalities related to nonmedical or inappropriate use of prescription opioids is climbing. Because the prevalence and adverse consequences of this threat are increasing, there is a pressing need for research that identifies the biobehavioral risk chain linking chronic pain, opioid analgesia, and addictive behaviors. To that end, the current manuscript draws upon current neuropsychopharmacologic research to provide a conceptual framework of the downward spiral leading to prescription opioid misuse and addiction among chronic pain patients receiving opioid analgesic pharmacotherapy. Addictive use of opioids is described as the outcome of a cycle initiated by chronic pain and negative affect and reinforced by opioidergic-dopamingeric interactions, leading to attentional hypervigilance for pain and drug cues, dysfunctional connectivity between self-referential and cognitive control networks in the brain, and allostatic dysregulation of stress and reward circuitry. Implications for clinical practice are discussed; multimodal, mindfulness-oriented treatment is introduced as a potentially effective approach to disrupting the downward spiral and facilitating recovery from chronic pain and opioid addiction.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Addiction; Allostasis; Attentional bias; Chronic pain; Default mode; Mindfulness; Opioid misuse; Reward

Mesh:

Substances:

Year:  2013        PMID: 23988582      PMCID: PMC3967721          DOI: 10.1016/j.neubiorev.2013.08.006

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  165 in total

1.  Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations.

Authors:  Eric L Garland; Susan A Gaylord; Olafur Palsson; Keturah Faurot; J Douglas Mann; William E Whitehead
Journal:  J Behav Med       Date:  2011-12-08

2.  Strategy-dependent dissociation of the neural correlates involved in pain modulation.

Authors:  Jane M Lawrence; Fumiko Hoeft; Kristen E Sheau; Sean C Mackey
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

Review 3.  Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches.

Authors:  Ingmar H A Franken
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-06       Impact factor: 5.067

4.  Electrophysiological evidence that drug cues have greater salience than other affective stimuli in opiate addiction.

Authors:  D I Lubman; N B Allen; L A Peters; J F W Deakin
Journal:  J Psychopharmacol       Date:  2008-01-21       Impact factor: 4.153

Review 5.  Review. The incentive sensitization theory of addiction: some current issues.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

Review 6.  Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review.

Authors:  Erica Amari; Jürgen Rehm; Elliot Goldner; Benedikt Fischer
Journal:  Can J Psychiatry       Date:  2011-08       Impact factor: 4.356

7.  Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial.

Authors:  Susan A Gaylord; Olafur S Palsson; Eric L Garland; Keturah R Faurot; Rebecca S Coble; J Douglas Mann; William Frey; Karyn Leniek; William E Whitehead
Journal:  Am J Gastroenterol       Date:  2011-06-21       Impact factor: 10.864

8.  Imaging human cerebral pain modulation by dose-dependent opioid analgesia: a positron emission tomography activation study using remifentanil.

Authors:  Klaus J Wagner; Till Sprenger; Eberhard F Kochs; Thomas R Tölle; Michael Valet; Frode Willoch
Journal:  Anesthesiology       Date:  2007-03       Impact factor: 7.892

9.  Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.

Authors:  Sarah Bowen; Neharika Chawla; Susan E Collins; Katie Witkiewitz; Sharon Hsu; Joel Grow; Seema Clifasefi; Michelle Garner; Anne Douglass; Mary E Larimer; Alan Marlatt
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

10.  Gender differences in risk factors for aberrant prescription opioid use.

Authors:  Robert N Jamison; Stephen F Butler; Simon H Budman; Robert R Edwards; Ajay D Wasan
Journal:  J Pain       Date:  2009-11-27       Impact factor: 5.820

View more
  72 in total

Review 1.  Mindfulness meditation-based pain relief: a mechanistic account.

Authors:  Fadel Zeidan; David R Vago
Journal:  Ann N Y Acad Sci       Date:  2016-06       Impact factor: 5.691

2.  Effects of craving on opioid use are attenuated after pain coping counseling in adults with chronic pain and prescription opioid addiction.

Authors:  Bryan G Messina; Matthew J Worley
Journal:  J Consult Clin Psychol       Date:  2019-10

3.  Perception of treatment need among adults with substance use disorders: Longitudinal data from a representative sample of adults in the United States.

Authors:  Scott J Moeller; Jonathan M Platt; Melody Wu; Renee D Goodwin
Journal:  Drug Alcohol Depend       Date:  2020-02-06       Impact factor: 4.492

4.  Anxiety sensitivity and opioid misuse and dependence among trauma-exposed adults with chronic pain.

Authors:  Michael J Zvolensky; Andrew H Rogers; Justin M Shepherd; Anka A Vujanovic; Jafar Bakhshaie
Journal:  J Behav Med       Date:  2020-02-18

Review 5.  Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).

Authors:  Bianca Blanch; Nicholas A Buckley; Leigh Mellish; Andrew H Dawson; Paul S Haber; Sallie-Anne Pearson
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

6.  Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users.

Authors:  Sara L Kroll; Emilija Nikolic; Franziska Bieri; Michael Soyka; Markus R Baumgartner; Boris B Quednow
Journal:  Psychopharmacology (Berl)       Date:  2018-10-11       Impact factor: 4.530

7.  Restructuring Hedonic Dysregulation in Chronic Pain and Prescription Opioid Misuse: Effects of Mindfulness-Oriented Recovery Enhancement on Responsiveness to Drug Cues and Natural Rewards.

Authors:  Eric L Garland; Matthew O Howard; Jon-Kar Zubieta; Brett Froeliger
Journal:  Psychother Psychosom       Date:  2017-02-10       Impact factor: 17.659

Review 8.  Positive psychological states in the arc from mindfulness to self-transcendence: extensions of the Mindfulness-to-Meaning Theory and applications to addiction and chronic pain treatment.

Authors:  Eric L Garland; Barbara L Fredrickson
Journal:  Curr Opin Psychol       Date:  2019-01-14

Review 9.  Using Screening Tests to Predict Aberrant Use of Opioids in Chronic Pain Patients: Caveat Emptor.

Authors:  Robert W Bailey; Kevin E Vowles
Journal:  J Pain       Date:  2017-06-29       Impact factor: 5.820

10.  Mindfulness is Associated With Increased Hedonic Capacity Among Chronic Pain Patients Receiving Extended Opioid Pharmacotherapy.

Authors:  Elizabeth A Thomas; Eric L Garland
Journal:  Clin J Pain       Date:  2017-02       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.